| 1 |
Gaas MY, Kaprin AD, Vorobyev NV, Rapoport LM, Korolev DO, Kalpinsky AS. Markers of local kidney cancer recurrence: A surgeon’s mistake or a pattern? Review. Urologia 2022. [DOI: 10.1177/03915603221140964] [Reference Citation Analysis]
|
| 2 |
Warli SM, Andy A, Mariedina CT, Nasution R, Kadar DD. A Rare Case of Sarcomatoid Renal Cell Carcinoma in a Young Adult Patient. RRU 2022;Volume 14:241-245. [DOI: 10.2147/rru.s370975] [Reference Citation Analysis]
|
| 3 |
Yang T, Wu Y, Zuo Y, Fu S, Xu Z, Yu N. Development and validation of prognostic nomograms and a web-based survival rate calculator for sarcomatoid renal cell carcinoma in pre- and post-treatment patients. Transl Androl Urol 2021;10:754-64. [PMID: 33718077 DOI: 10.21037/tau-20-1192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Donskov F. Renal cell carcinoma with non-clear cell histology or sarcomatoid differentiation: recent insight in an unmet clinical need. Ann Transl Med 2021;9:97. [PMID: 33569399 DOI: 10.21037/atm-20-7009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 5 |
Tretiakova M, Williamson SR. Kidney Tumor. Practical Genitourinary Pathology 2021. [DOI: 10.1007/978-3-030-57141-2_1] [Reference Citation Analysis]
|
| 6 |
Zhi H, Feng M, Liu S, Na T, Zhang N, BiLiGe W. Prognostic Significance of Sarcomatoid Differentiation in Patients With Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis. Front Oncol 2020;10:591001. [PMID: 33134181 DOI: 10.3389/fonc.2020.591001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
An J, Park CK, Kim M, Joo JW, Cho NH. HNF-1β as an immunohistochemical marker for distinguishing chromophobe renal cell carcinoma and hybrid oncocytic tumors from renal oncocytoma. Virchows Arch 2021;478:459-70. [PMID: 32816058 DOI: 10.1007/s00428-020-02912-7] [Reference Citation Analysis]
|
| 8 |
Ji B, Li D, Fu S, Zhang Z, Yang T, Wu Y, Zuo Y, Xu Z, Yu N. A Population Study to Identify Candidates for Cytoreductive Nephrectomy in Patients with Metastatic Sarcomatoid Renal Cell Carcinoma from the Surveillance, Epidemiology, and End Results (SEER) Database. Med Sci Monit 2020;26:e921297. [PMID: 32516796 DOI: 10.12659/MSM.921297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 9 |
Ji B, Li D, Fu S, Zhang Z, Yang T, Wu Y, Zuo Y, Xu Z, Yu N. Propensity-score matched comparison of partial versus radical nephrectomy for T1N0M0 sarcomatoid renal cell carcinoma. Transl Androl Urol 2020;9:250-7. [PMID: 32420130 DOI: 10.21037/tau.2020.02.19] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 10 |
Polanco Pujol L, Herranz Amo F, Caño Velasco J, Subirá Ríos D, Moralejo Gárate M, Hernández Cavieres J, Barbas Bernardos G, Bueno Chomón G, Rodríguez Fernández E, Hernández Fernández C. Recurrence risk groups after nephrectomy for renal cell carcinoma. Actas Urol Esp (Engl Ed) 2020;44:111-8. [PMID: 31836313 DOI: 10.1016/j.acuro.2019.08.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 11 |
Polanco Pujol L, Herranz Amo F, Caño Velasco J, Subirá Ríos D, Moralejo Gárate M, Hernández Cavieres J, Barbas Bernardos G, Bueno Chomón G, Rodríguez Fernández E, Hernández Fernández C. Recurrence risk groups after nephrectomy for renal cell carcinoma. Actas Urológicas Españolas (English Edition) 2020;44:111-118. [DOI: 10.1016/j.acuroe.2019.08.004] [Reference Citation Analysis]
|
| 12 |
Debien V, Thouvenin J, Lindner V, Barthélémy P, Lang H, Flippot R, Malouf GG. Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities. Cancers (Basel) 2019;12:E99. [PMID: 31906050 DOI: 10.3390/cancers12010099] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 13 |
Silagy AW, Mano R, Blum KA, DiNatale RG, Marcon J, Tickoo SK, Reznik E, Coleman JA, Russo P, Hakimi AA. The Role of Cytoreductive Nephrectomy for Sarcomatoid Renal Cell Carcinoma: A 29-Year Institutional Experience. Urology 2020;136:169-75. [PMID: 31726184 DOI: 10.1016/j.urology.2019.08.058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 14 |
Kim SH, Park B, Hwang EC, Hong SH, Jeong CW, Kwak C, Byun SS, Chung J. Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma. Front Oncol 2019;9:859. [PMID: 31552183 DOI: 10.3389/fonc.2019.00859] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 15 |
Wang YS, Shuang WB, Yin KQ, Tong XN, Xia MC, Yang HS. Analysis of the factors influencing the survival time of patients with sarcomatoid renal cell carcinoma. Mol Clin Oncol 2019;11:405-10. [PMID: 31475069 DOI: 10.3892/mco.2019.1900] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 16 |
Fan B, Wang W, Zhang X, Sun M, Wang X, Chen Z, Liu W, Wang Q, Yu N, Li X. Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma. BMC Cancer 2019;19:534. [PMID: 31159774 DOI: 10.1186/s12885-019-5736-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
